MATVAX-RSV: Long term immunogenicity of maternal RSV vaccine given during pregnancy - mother of a child 3 and under
Are you a woman 18-49? Do you have direct exposure to at least 1 child, 3 years of age or younger for 3 or more days per week? You may be eligible for a research study that compares the antibody levels (cells that fight infection) in the blood of women who received the RSV (respiratory syncytial virus) vaccine during pregnancy to women who have not received it over time. Compensation provided.
